Vivek Jain - 06 Mar 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Mar 2022, 18:11:07 UTC
Prior SEC filing
04 Mar 2022
Next SEC filing
23 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain

Key filing fact

Vivek Jain filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 08 Mar 2022.

Key facts

  • This page summarizes Vivek Jain's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
  • 10 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 08 Mar 2022, 18:11.

Change

  • Previous filing in this sequence was filed on 04 Mar 2022.
  • Current net transaction value: -$411,038.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICUI transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,772
Change %
+14%
Price
$0.000000
Shares after
14,551
Date
06 Mar 2022
Ownership
Direct
ICUI transaction

Common Stock

Tax liability

Transaction value
$226,411
Shares
-932
Change %
-6.4%
Price
$242.93
Shares after
13,619
Date
06 Mar 2022
Ownership
Direct
ICUI transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,444
Change %
+11%
Price
$0.000000
Shares after
15,063
Date
06 Mar 2022
Ownership
Direct
Footnotes
F1
ICUI transaction

Common Stock

Tax liability

Transaction value
$184,627
Shares
-760
Change %
-5%
Price
$242.93
Shares after
14,303
Date
06 Mar 2022
Ownership
Direct
ICUI transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,524
Change %
+18%
Price
$0.000000
Shares after
16,827
Date
08 Mar 2022
Ownership
Direct
ICUI transaction

Common Stock

Tax liability

Transaction value
$0
Shares
-1,328
Change %
-7.9%
Price
$0.000000
Shares after
15,499
Date
08 Mar 2022
Ownership
Direct
ICUI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
60,000
Date
06 Mar 2022
Ownership
by Trust
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICUI transaction Derivative

Common Stock

Options Exercise

Transaction value
$0
Shares
-1,772
Change %
-50%
Price
$0.000000
Shares after
1,773
Date
06 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,772
Exercise price
$0.000000
Footnotes
F3, F4, F5
ICUI transaction Derivative

Common Stock

Options Exercise

Transaction value
$0
Shares
-2,524
Change %
-33%
Price
$0.000000
Shares after
5,050
Date
08 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,524
Exercise price
$0.000000
Footnotes
F3, F4
ICUI transaction Derivative

Common Stock

Award

Transaction value
$0
Shares
+9,654
Change %
Price
$0.000000
Shares after
9,654
Date
07 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,654
Exercise price
$0.000000
Footnotes
F1, F3, F4, F5
ICUI transaction Derivative

Common Stock

Options Exercise

Transaction value
$0
Shares
-1,444
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,444
Exercise price
Footnotes
F1, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These securities are Restricted Stock Units.

Footnote F2

This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

Footnote F3

There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Footnote F4

One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Footnote F5

These are restricted stock units that fully vest 3 years from the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .